Mds News - MDZ

- Tender offer statement by Issuer (SC TO-I)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER...

- Report of Foreign Issuer (6-K)

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule...

MDS Announces Substantial Issuer Bid

TORONTO, Feb. 19 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life...

- Statement of Ownership (SC 13G)

OMB APPROVAL OMB Number: 3235-0287 Expires: February 28, 2011 Estimated average burden hours per response………11...

- Statement of Ownership (SC 13G)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information...

- Report of Foreign Issuer (6-K)

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule...

MDS Announces Agreements to Divest MDS Pharma Services' Early Stage Business

Company Focused on Building MDS Nordion TORONTO, Feb. 10 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of...

- Amended Statement of Beneficial Ownership (SC 13D/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of...

MDS Nordion's TheraSphere(R) for Unresectable Liver Cancer (HCC) Now Covered by Two Large U.S. Insurers

Health Insurance Companies Amend Policy on Radioembolization Coverage OTTAWA, Feb. 5 /PRNewswire-FirstCall/ -- MDS Nordion, a global leader in...

- Report of Foreign Issuer (6-K)

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule...

MDS Inc. Announces Appointment of William D. Anderson as Chair of Board of Directors

TORONTO, Feb. 1 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global...

- Report of Foreign Issuer (6-K)

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule...

MDS Inc. Completes Divestiture of MDS Analytical Technologies

TORONTO, Feb. 1 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life...

- Amended Statement of Ownership (SC 13G/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities...

UPDATE: FTC Clears Danaher Buy Of MDS Unit, With Conditions

The U.S. Federal Trade Commission on Wednesday cleared Danaher Corp.'s (DHR) acquisition of MDS Analytical Technologies but required the companies...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Mds (MDZ)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

MDZ News

- Tender offer statement by Issuer (SC TO-I)

- Report of Foreign Issuer (6-K)

MDS Announces Substantial Issuer Bid

- Statement of Ownership (SC 13G)

- Statement of Ownership (SC 13G)

- Report of Foreign Issuer (6-K)

MDS Announces Agreements to Divest MDS Pharma Services' Early Stage Business

- Amended Statement of Beneficial Ownership (SC 13D/A)

MDS Nordion's TheraSphere(R) for Unresectable Liver Cancer (HCC) Now Covered by Two Large U.S. Insurers

- Report of Foreign Issuer (6-K)

MDS Inc. Announces Appointment of William D. Anderson as Chair of Board of Directors

- Report of Foreign Issuer (6-K)

MDS Inc. Completes Divestiture of MDS Analytical Technologies

- Amended Statement of Ownership (SC 13G/A)

UPDATE: FTC Clears Danaher Buy Of MDS Unit, With Conditions

MDZ Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Mds (MDZ) News

Mds (MDZ)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

MDZ News

- Tender offer statement by Issuer (SC TO-I)

- Report of Foreign Issuer (6-K)

MDS Announces Substantial Issuer Bid

- Statement of Ownership (SC 13G)

- Statement of Ownership (SC 13G)

- Report of Foreign Issuer (6-K)

MDS Announces Agreements to Divest MDS Pharma Services' Early Stage Business

- Amended Statement of Beneficial Ownership (SC 13D/A)

MDS Nordion's TheraSphere(R) for Unresectable Liver Cancer (HCC) Now Covered by Two Large U.S. Insurers

- Report of Foreign Issuer (6-K)

MDS Inc. Announces Appointment of William D. Anderson as Chair of Board of Directors

- Report of Foreign Issuer (6-K)

MDS Inc. Completes Divestiture of MDS Analytical Technologies

- Amended Statement of Ownership (SC 13G/A)

UPDATE: FTC Clears Danaher Buy Of MDS Unit, With Conditions

MDZ Discussion

Your Recent History